CUSABIO Antibodies against Rare Species of Virus

Viral antibodies serve as pivotal tools in infectious disease control, vaccine development, and gene therapy, driving scientific breakthroughs and translational advancements. Viruses' unique replication strategies and host interaction mechanisms position them as focal points for drug target discovery, diagnostic reagent development, and immunotherapy research. By enabling high-specificity recognition of viral surface proteins (e.g., hemagglutinin [HA], Spike protein), non-structural proteins, and critical enzymes, viral antibodies provide essential support for elucidating viral invasion mechanisms, screening neutralizing antibody therapeutics, and constructing viral detection platforms.

In vaccine development, viral antibodies precisely map antigenic epitopes to accelerate immunogenicity evaluation of candidate vaccines. In antiviral therapy, broad-spectrum neutralizing antibodies offer novel intervention strategies for mutable pathogens like HIV and influenza. For gene therapy vectors (e.g., AAV, lentivirus), antibody tools enhance optimization and safety monitoring of targeted delivery systems. Furthermore, integration of viral antibodies with technologies like CRISPR is pioneering new paradigms in viral genome editing and functional studies.

CUSABIO Rare Species Antibody Series – Viral Antibodies Solutions – is designed to meet cutting-edge research needs. Covering positive/negative-sense RNA viruses, DNA viruses, and retroviruses, this portfolio offers high-affinity monoclonal and polyclonal antibody combinations to support viral-host interactome mapping, viral protein functional studies, and innovative therapy development. Coupled with antibody engineering, these reagents extend applications to CAR-T cell therapies, viral capture nanomaterial design, and more, injecting precision medicine innovations into infectious disease control and gene therapy.

Application Scenarios

Drug Target Screening

Vaccine Development

Heterologous Protein Production

Disease Model Mechanistic

Diagnostic Assay Development

Biosafety Testing